{"id":"W2255223807","doi":"10.1093/eurheartj/ehv643","title":"Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1","year":2016,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Cilag; Janssen Pharmaceuticals; St. Jude Medical; AstraZeneca; Allergan; National Institutes of Health; H. Lundbeck A/S; Servier; Astellas Pharma; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; Fondation Leducq; British Heart Foundation; European Society of Cardiology; Boston Scientific Corporation; Bayer Vital; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alere; Bayer HealthCare; European Commission; Sanofi; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Pfizer","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Warfarin; Internal medicine; Cardiology; Coronary artery disease; Concomitant; Embolism; Cardioversion; Thrombus; Anticoagulant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001365117,0.0006749865,0.001644489,0.001228455,0.000208617,0.001145991,0.0005335766,0.001404161,0.002611988],"category_scores_gemma":[0.004586291,0.0002612259,0.001235007,0.00133604,0.0004981779,0.001444587,0.0004437564,0.000859737,0.0005795178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005064353,"about_ca_system_score_gemma":0.0009160994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007520692,"about_ca_topic_score_gemma":0.00121196,"domain_scores_codex":[0.9987231,0.0004994543,0.0004229062,0.0001524995,0.000168403,0.00003368422],"domain_scores_gemma":[0.997776,0.001588759,0.0003891996,0.00003390581,0.0001839968,0.00002816514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004675983,0.00007952403,0.001770102,0.1367072,0.0009084404,0.0002124416,0.0002788208,0.0003118645,0.001735098,0.001941039,0.02788036,0.8277075],"study_design_scores_gemma":[0.0003471804,0.001088422,0.02068081,0.1565818,0.006470661,0.004957243,0.0005375274,0.0005348449,0.001753796,0.00463866,0.80231,0.00009912251],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006191644,0.9973387,0.0002238525,0.0009155803,0.0003273676,0.00002450707,0.00003906494,0.000003887964,0.000507822],"genre_scores_gemma":[0.005352145,0.9904218,0.0008835284,0.001814678,0.0008875678,0.00007114044,0.00008461505,0.000004318469,0.0004802703],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002611988,"threshold_uncertainty_score":0.008737981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1625148361972724,"score_gpt":0.3966455082149066,"score_spread":0.2341306720176341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}